Agenus Inc (NAS:AGEN)
$ 3.105 -0.795 (-20.38%) Market Cap: 66.98 Mil Enterprise Value: 71.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q2 2024 Agenus Inc Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: $5.28 (+3.94%)
Operator

Good morning and welcome to Agenus second quarter 2024 conference call and webcast. All participants will be in a listen-only mode until the question-and-answer session. Please note, this event is being recorded. If anyone has any objections, you may disconnect at this time.

(Operator instructions) I would now like to turn the call over to Zack Armen, Head of Investor Relations at Agenus. Zack, please go ahead.

Zack Armen
Agenus Inc - Head of IR

Thank you, Leonardo, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and timelines, as well as timelines for data release and partnership opportunities among other updates.

These statements are subjects to risks and uncertainties, and we refer you to our SEC filings available on our website for more details on these risks.

Joining me today are Dr. Garo

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot